NJ Jury Orders Roche To Pay $1.5M For Accutane User's IBD

Law360, New York (March 11, 2014, 7:02 PM EDT) -- A New Jersey jury on Tuesday awarded at retrial over $1.5 million to a woman who developed a form of inflammatory bowel disease after taking Hoffman-LaRoche Inc.’s acne drug Accutane, representing the plaintiff's second victory, with her earlier verdict having been overturned on appeal.

Kamie Kendall Rees was awarded a judgment of $1.5 million in compensatory damages plus roughly $88,000 in past medical expenses, after a monthlong trial in which her attorneys presented evidence that Roche was aware Accutane can cause IBD and failed to adequately...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.